VTX-801

· Vivet Therapeutics SAS

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VTX-801, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease [Phase 1, Phase 2]